INDV
Price
$23.88
Change
-$0.48 (-1.97%)
Updated
Aug 28 closing price
Capitalization
2.98B
55 days until earnings call
KSPHF
Price
$30.28
Change
+$3.15 (+11.61%)
Updated
Aug 6 closing price
Capitalization
1.21B
Interact to see
Advertisement

INDV vs KSPHF

Header iconINDV vs KSPHF Comparison
Open Charts INDV vs KSPHFBanner chart's image
Indivior
Price$23.88
Change-$0.48 (-1.97%)
Volume$1.37M
Capitalization2.98B
Kissei Pharmaceutical
Price$30.28
Change+$3.15 (+11.61%)
Volume$100
Capitalization1.21B
INDV vs KSPHF Comparison Chart in %
Loading...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INDV vs. KSPHF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDV is a Hold and KSPHF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (INDV: $23.88 vs. KSPHF: $30.28)
Brand notoriety: INDV and KSPHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: INDV: 43% vs. KSPHF: 100%
Market capitalization -- INDV: $2.98B vs. KSPHF: $1.21B
INDV [@Pharmaceuticals: Generic] is valued at $2.98B. KSPHF’s [@Pharmaceuticals: Generic] market capitalization is $1.21B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDV’s FA Score shows that 0 FA rating(s) are green whileKSPHF’s FA Score has 2 green FA rating(s).

  • INDV’s FA Score: 0 green, 5 red.
  • KSPHF’s FA Score: 2 green, 3 red.
According to our system of comparison, KSPHF is a better buy in the long-term than INDV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDV’s TA Score shows that 2 TA indicator(s) are bullish while KSPHF’s TA Score has 1 bullish TA indicator(s).

  • INDV’s TA Score: 2 bullish, 5 bearish.
  • KSPHF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, KSPHF is a better buy in the short-term than INDV.

Price Growth

INDV (@Pharmaceuticals: Generic) experienced а -0.71% price change this week, while KSPHF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.15%. For the same industry, the average monthly price growth was +68.06%, and the average quarterly price growth was +81.85%.

Reported Earning Dates

INDV is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.15% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($2.98B) has a higher market cap than KSPHF($1.21B). INDV has higher P/E ratio than KSPHF: INDV (29.48) vs KSPHF (16.28). INDV YTD gains are higher at: 92.116 vs. KSPHF (21.120). KSPHF has higher annual earnings (EBITDA): 18.6B vs. INDV (261M). KSPHF has more cash in the bank: 50B vs. INDV (510M). INDV has less debt than KSPHF: INDV (366M) vs KSPHF (1.26B). KSPHF has higher revenues than INDV: KSPHF (81.1B) vs INDV (1.17B).
INDVKSPHFINDV / KSPHF
Capitalization2.98B1.21B247%
EBITDA261M18.6B1%
Gain YTD92.11621.120436%
P/E Ratio29.4816.28181%
Revenue1.17B81.1B1%
Total Cash510M50B1%
Total Debt366M1.26B29%
FUNDAMENTALS RATINGS
INDV vs KSPHF: Fundamental Ratings
INDV
KSPHF
OUTLOOK RATING
1..100
8944
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
18
Undervalued
PROFIT vs RISK RATING
1..100
5232
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3541
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KSPHF's Valuation (18) in the null industry is significantly better than the same rating for INDV (94). This means that KSPHF’s stock grew significantly faster than INDV’s over the last 12 months.

KSPHF's Profit vs Risk Rating (32) in the null industry is in the same range as INDV (52). This means that KSPHF’s stock grew similarly to INDV’s over the last 12 months.

KSPHF's SMR Rating (100) in the null industry is in the same range as INDV (100). This means that KSPHF’s stock grew similarly to INDV’s over the last 12 months.

INDV's Price Growth Rating (35) in the null industry is in the same range as KSPHF (41). This means that INDV’s stock grew similarly to KSPHF’s over the last 12 months.

INDV's P/E Growth Rating (100) in the null industry is in the same range as KSPHF (100). This means that INDV’s stock grew similarly to KSPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDVKSPHF
RSI
ODDS (%)
Bearish Trend 5 days ago
51%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
60%
Bullish Trend 1 day ago
18%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
20%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
24%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
23%
Advances
ODDS (%)
Bullish Trend 10 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
72%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
62%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KSPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSPJX30.94N/A
N/A
Principal Large Cap S&P 500 Index J
SPQAX15.31N/A
N/A
PGIM Jennison Global Equity Income A
PPNPX13.92N/A
N/A
Principal SmallCap Growth I R5
FMPFX39.49N/A
N/A
Nuveen Small Cap Growth Opp R6
WCFOX12.56N/A
N/A
WCM Focused International Opps Inv

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and CAIHF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and CAIHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
-1.97%
CAIHF - INDV
27%
Poorly correlated
N/A
ASRT - INDV
26%
Poorly correlated
+5.32%
ALKS - INDV
25%
Poorly correlated
-1.09%
MKKGY - INDV
24%
Poorly correlated
-0.10%
HROW - INDV
24%
Poorly correlated
+0.52%
More

KSPHF and

Correlation & Price change

A.I.dvisor tells us that KSPHF and LVRLF have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KSPHF and LVRLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KSPHF
1D Price
Change %
KSPHF100%
N/A
LVRLF - KSPHF
5%
Poorly correlated
+14.75%
INDV - KSPHF
1%
Poorly correlated
-1.97%
MILFF - KSPHF
1%
Poorly correlated
N/A
HSTI - KSPHF
1%
Poorly correlated
N/A
HTSUF - KSPHF
0%
Poorly correlated
N/A
More